Emergency Medicine News

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets the immune checkpoint B7-H3 for diffuse intrinsic pontine glioma, or DIPG, a rare incurable pediatric brain tumor.

Two major policy updates were published in 2024 regarding opioids and children.

One in six hospitals that accepted pediatric patients in 2019 closed their pediatric services by 2021, according to a study published in JAMA Network Open.

BOSTON — Decisions about pediatric noninvasive ventilation need to align with the child’s and family’s goals at all stages of the child’s life and at the end of it as well, according to a presentation at the CHEST Annual Meeting.

One in five febrile infants and toddlers with UTIs were missed by automated screening methods because they did not have pyuria, according to a study published in Pediatrics.

Seizures caused by swallowing medications or illegal substances among youth have significantly risen over the past 15 years, data presented at the European Emergency Medicine Congress showed.

A healthy, 10-year-old boy seeks care for a sore left cheek.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

The FDA has approved a supplemental new drug application for a once-daily, extended-release therapeutic to treat cataplexy or excessive daytime sleepiness in patients with narcolepsy aged 7 years and older, according to the manufacturer.